TP53 and Alzheimer disease: Since oxidative stress has been considered a crucial factor that contributes to neurodegenerative processes like AD [31]–[33], p53 could be a therapeutic target to reduce the levels of ROS, and in this way prevent or attenuate neuronal death in neurodegenerative disorders such as MCI and AD.